Article
Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia.
Haematologica - 1 Aug 2010
Casonato Alessandra, Gallinaro Lisa, Cattini Maria Grazia, Pontara Elena, Padrini Roberto, Bertomoro Antonella, Daidone Viviana, Pagnan Antonio
Abstract excerpt
BACKGROUND: Type 2B von Willebrand factor (VWF) is characterized by gain of function mutations in the A1 domain inducing a greater affinity for platelet GPIb, possibly associated with the disappearance of large VWF multimers and thrombocytopenia. DESIGN AND METHODS: VWF survival was explored using 1-desamino-8-D-arginine vasopressin (DDAVP) in 18 patients with type 2B von Willebrand disease (VWD) and compared...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
